Brief: India's Aarti Drugs June-Qtr Consol Net Profit Rises
21/07/2023 12:18
July 21 (Reuters) - Aarti Drugs Ltd ADRG.NS :
* INDIA'S AARTI DRUGS JUNE-QUARTER CONSOL NET PROFIT 478.5
MILLION
RUPEES VERSUS 347.9 MILLION RUPEES
* AARTI DRUGS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS
6.61
BILLION RUPEES VERSUS 6.22 BILLION RUPEES
* APPROVED BUYBACK OF SHARES WORTH UP TO 598.5 MILLION
RUPEES
* APPROVED BUYBACK PRICE AT 900 RUPEES PER SHARE
Source text for Eikon: ID:nBSE7ryzNN
Further company coverage: ADRG.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees